 BURNABY, British Columbia, April 25, 2022 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a neurology-focused biopharmaceutical company today announced that Xenons management team will participate in the following investor conferences: 